55 East Monroe Street
Suite 3300
Chicago, Illinois 60603-5792

Allergan Pleads Guilty, Settles Botox Investigation

September 2, 2010
ABC News

Pharmaceutical manufacturer Allergan pled guilty for its off-label promotion of Botox and will pay $600 million to settle additional charges in a longstanding federal investigation.

Botox is best known for its ability to smooth out wrinkles, but it is also approved to treat spasms in the neck, wrist and fingers, eye muscle disorders and excessive arm sweating.

Allergan released a statement Wednesday saying it would plead guilty to one misdemeanor charge of "misbranding" for marketing Botox as a treatment for unapproved uses such as for headache, pain and cerebral palsy in children. To read the complete article click here.

Attorneys at law



False claims act basics


Our successes

Our website uses cookies to improve your experience. By continuing to use this website, you are agreeing to our Cookie Policy.